Live Breaking News & Updates on Nasdaq kala

Stay informed with the latest breaking news from Nasdaq kala on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nasdaq kala and stay connected to the pulse of your community

KALA BIO (NASDAQ:KALA) Trading Up 0.1%

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) was up 0.1% during mid-day trading on Monday . The company traded as high as $7.10 and last traded at $6.97. Approximately 14,248 shares were traded during trading, a decline of 64% from the average daily volume of 39,852 shares. The stock had previously closed at $6.96. […]

Markt-iwicki , Virtu-financial , Renaissance-technologies , Nasdaq , Kala-bio-inc , Company-profile , Millennium-management , Securities-exchange-commission , Goldman-sachs-group-inc , Get-free-report , Exchange-commission

KALA BIO, Inc. (NASDAQ:KALA) CEO Sells $30,547.47 in Stock

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 4,539 shares of KALA BIO stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $6.73, for a total value of $30,547.47. Following the sale, the chief executive officer now directly owns 286,315 shares of […]

Markt-iwicki , Mirabella-financial-services , Renaissance-technologies , Company-profile , Wealth-concepts , Kala-bio-inc , Goldman-sachs-group-inc , Nasdaq , Get-free-report , Financial-services , Sachs-group

KALA BIO, Inc. (NASDAQ:KALA) CEO Mark T. Iwicki Sells 4,539 Shares

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 4,539 shares of KALA BIO stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $6.73, for a total value of $30,547.47. Following the completion of the sale, the chief executive officer now […]

Markt-iwicki , Mirabella-financial-services , Kala-bio-inc , Wealth-concepts , Renaissance-technologies , Nasdaq , Get-free-report , Street-corp , Street-group , Kala-bio , Nasdaq-kala

Board of Trustees of The Leland Stanford Junior University Boosts Stock Holdings in KALA BIO, Inc. (NASDAQ:KALA)

Board of Trustees of The Leland Stanford Junior University raised its holdings in KALA BIO, Inc. (NASDAQ:KALA – Free Report) by 85.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,127 shares of the company’s stock after purchasing an additional 9,748 […]

United-states , America , Board-of-trustees , Leland-stanford-junior-university , America-corp , Nasdaq , Securities-exchange-commission , Virtu-financial , Dimensional-fund-advisors , Blackrock-inc , Kala-bio-inc

KALA BIO, Inc. (NASDAQ:KALA) Short Interest Update

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 100,000 shares, an increase of 48.4% from the September 15th total of 67,400 shares. Currently, 4.9% of the company’s stock are short sold. Based on an […]

Kala-bio-inc , Renaissance-technologies , Wealth-concepts , Nasdaq , Mirabella-financial-services , Get-free-report , Street-corp , Street-group , Kala-bio , Nasdaq-kala , Kala

KALA BIO, Inc. (NASDAQ:KALA) Short Interest Update

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totalling 9,200 shares, a drop of 87.8% from the August 15th total of 75,500 shares. Approximately 0.5% of the company’s shares are short sold. Based on an […]

Kala-bio-inc , Millennium-management , Nasdaq , Company-profile , Renaissance-technologies , Virtu-financial , Goldman-sachs-group-inc , Get-free-report , Street-corp , Sachs-group , Kala-bio

Kala Pharmaceuticals (NASDAQ:KALA) Stock Price Down 4.5%

Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Free Report)’s share price was down 4.5% during mid-day trading on Thursday . The stock traded as low as $14.21 and last traded at $14.37. Approximately 68,731 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 693,209 shares. The stock had previously closed […]

Blackrock-inc , Nasdaq , Millennium-management , Institutional-trading-of-kala-pharmaceuticals , Kala-pharmaceuticals , Virtu-financial , News-ratings-for-kala-pharmaceuticals-daily , Kala-pharmaceuticals-inc , Renaissance-technologies , Columbus-asset-advisors , Kala-pharmaceuticals-stock-down

Clear Street LLC Invests $1.88 Million in Kala Pharmaceuticals, Inc. (NASDAQ:KALA)

Clear Street LLC acquired a new position in shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 49,390 shares of the company’s stock, valued at approximately $1,884,000. Kala Pharmaceuticals comprises about 0.0% of Clear Street […]

Justin-hanes , Roberts-langer , Kala-pharmaceuticals , Renaissance-technologies , Mirabella-financial-services , Wealth-concepts , Kala-pharmaceuticals-profile , Kala-pharmaceuticals-stock-down , Columbus-asset-advisors , Quarter-for-kala-pharmaceuticals , Kala-pharmaceuticals-inc

Kala Pharmaceuticals (NASDAQ:KALA) Trading Up 3.1%

Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) shares shot up 3.1% during mid-day trading on Monday . The stock traded as high as $15.97 and last traded at $15.80. Approximately 78,700 shares traded hands during trading, a decline of 92% from the average daily volume of 937,802 shares. The stock had previously closed at $15.32. […]

Justin-hanes , Roberts-langer , Mirabella-financial-services , Kala-pharmaceuticals-price-performance , Kala-pharmaceuticals-inc , News-ratings-for-kala-pharmaceuticals-daily , Renaissance-technologies , Vahanian-associates-financial-planning-inc , Kala-pharmaceuticals , Nasdaq , Columbus-asset-advisors

Kala Pharmaceuticals (NASDAQ:KALA) PT Raised to $22.00

Kala Pharmaceuticals (NASDAQ:KALA – Get Rating) had its price objective hoisted by investment analysts at HC Wainwright from $20.00 to $22.00 in a research note issued to investors on Wednesday, The Fly reports. HC Wainwright’s target price would suggest a potential upside of 28.58% from the company’s previous close. Kala Pharmaceuticals Stock Up 0.4 % […]

Roberts-langer , Justin-hanes , Mirabella-financial-services , Kala-pharmaceuticals-inc , Wealth-concepts , Hedge-funds-weigh-in-on-kala-pharmaceuticals , News-ratings-for-kala-pharmaceuticals-daily , Kala-pharmaceuticals , Kala-pharmaceuticals-stock , Renaissance-technologies , Nasdaq